2026 SPS Denver | HELIOS B Clinical Trial: Vutrisiran in the Management of Transthyretin-Mediated Amyloidosis Cardiomyopathy Patients

2026 SPS Denver | HELIOS B Clinical Trial: Vutrisiran in the Management of Transthyretin-Mediated Amyloidosis Cardiomyopathy Patients

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
May 25, 2026
Last Review
May 25, 2026
Expires
May 25, 2029

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Accreditation

NA